Form 4: Alector CEO Arnon Rosenthal Acquires 610,500 Shares of Common Stock
SEC Form 4 Filing
Alector's CEO, Arnon Rosenthal, acquired 610,500 shares of common stock through restricted stock units vesting quarterly, while also reporting indirect ownership through family trusts.
Summary
- On October 1, 2024, Arnon Rosenthal, CEO of Alector, Inc., acquired 610,500 shares of Alector's common stock.
- These shares were acquired through restricted stock units (RSUs) that will vest in 12 equal quarterly installments starting December 1, 2024.
- The acquisition price was $0.00 per share.
- Following the transaction, Rosenthal directly owns 2,559,246 shares.
- Rosenthal also indirectly owns shares through several trusts: The Rosenthal Family Revocable Trust (1,972,875 shares), Adi Rosenthal 2007 Trust (652,500 shares), Noam Rosenthal 2007 Trust (652,500 shares), and Shani Rosenthal 2007 Trust (652,500 shares).
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO acquiring shares is generally a good sign, but it's part of a pre-planned vesting schedule.
Positives
- The CEO's acquisition of shares may signal confidence in the company's future prospects.
Future Outlook
The vesting schedule of the RSUs indicates a continued alignment of the CEO's interests with the long-term performance of the company.
Industry Context
Form 4 filings are standard disclosures for insider transactions and are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The CEO's increased stake in the company could potentially align his interests more closely with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| November 4, 1994 | Date of The Rosenthal Family Revocable Trust |
| June 9, 1999 | Date of restatement of The Rosenthal Family Revocable Trust |
| March 27, 2007 | Date of Adi Rosenthal 2007 Trust, Noam Rosenthal 2007 Trust, and Shani Rosenthal 2007 Trust |
| October 1, 2024 | Date of transaction: Arnon Rosenthal acquired 610,500 shares of Alector's common stock. |
| October 2, 2024 | Date of signature on the Form 4 filing. |
| December 1, 2024 | Start date for the quarterly vesting of the restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.